Ophthalmology · Waltham, MA
NPI
1003052788
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1440 Main Street, Suite 201
Waltham, MA, 02451
Phone (781) 891-6377
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
23,023 services
Medicare patients, 2024
852
Average age 74
Drug cost, 2024
$14.3M
4,913 prescriptions
Company payments, 2025
$142K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen D Anesi was code 99214 (office e&m - established), 853 times for 273 patients. In total Stephen D Anesi billed 23,023 services in 111 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 853 | 273 | $109.73 | $94K |
| 92014 Ophthalmological E&M | Office | 786 | 470 | $108.57 | $85K |
| 85025 Blood Count | Office | 638 | 166 | $7.57 | $4,827 |
| 82565 Clinical Chemistry | Office | 631 | 165 | $5.01 | $3,161 |
| 84460 Clinical Chemistry | Office | 631 | 166 | $5.18 | $3,268 |
| 84450 Clinical Chemistry | Office | 631 | 166 | $5.06 | $3,193 |
| 84520 Clinical Chemistry | Office | 627 | 165 | $3.86 | $2,421 |
| 82947 Clinical Chemistry | Office | 618 | 159 | $3.84 | $2,374 |
| 82977 Clinical Chemistry | Office | 594 | 149 | $7.04 | $4,184 |
| 36415 Venipuncture Blood Collection | Office | 566 | 144 | $8.65 | $4,896 |
| 92134 Computerized Ophthalmic Imaging | Office | 537 | 338 | $34.78 | $19K |
| 96415 Chemotherapy Administration | Office | 442 | 29 | $26.84 | $12K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 408 | 17 | $264.16 | $108K |
| J7314 Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg | Office | 271 | 11 | $403.76 | $109K |
| 92136 Ultrasound - Nonspecific | Office | 236 | 116 | $20.53 | $4,844 |
By year: 2022 $660K for 8,033 services; 2023 $893K for 15,385 services; 2024 $1.1M for 23,023 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 638 | 166 | $7.57 | $4,827 |
| 82565 Clinical Chemistry | 631 | 165 | $5.01 | $3,161 |
| 84450 Clinical Chemistry | 631 | 166 | $5.06 | $3,193 |
| 84460 Clinical Chemistry | 631 | 166 | $5.18 | $3,268 |
| 84520 Clinical Chemistry | 627 | 165 | $3.86 | $2,421 |
| 82947 Clinical Chemistry | 618 | 159 | $3.84 | $2,374 |
| 82977 Clinical Chemistry | 594 | 149 | $7.04 | $4,184 |
| 36415 Venipuncture Blood Collection | 566 | 144 | $8.65 | $4,896 |
| 88341 Immunohistochemistry | 162 | 16 | $89.23 | $14K |
| 88350 Immunohistochemistry | 110 | 19 | $112.48 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen D Anesi prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 557 prescriptions and refills. In total Stephen D Anesi wrote 4,913 Medicare prescriptions that cost $14.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 557 | 983 | 127 | $13K |
| Prednisolone Acetate Generic | 353 | 476 | 155 | $14K |
| Valacyclovir Valacyclovir Hcl | 217 | 456 | 68 | $12K |
| Brimonidine Tartrate Generic | 205 | 345 | 57 | $14K |
| Doxycycline Hyclate Generic | 204 | 384 | 57 | $4,188 |
| Timolol Maleate Generic | 193 | 369 | 59 | $2,284 |
| Cyclosporine Modified Cyclosporine, Modified | 177 | 313 | 41 | $16K |
| Latanoprost Generic | 165 | 346 | 56 | $2,548 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 151 | 321 | 58 | $2,420 |
| Humira(Cf) Pen Adalimumab | 148 | 162 | 17 | $1.3M |
| Acthar Corticotropin | 120 | 131 | 18 | $8.1M |
| Restasis Cyclosporine | 106 | 219 | 34 | $129K |
| Moxifloxacin Moxifloxacin Hcl | 101 | 126 | 36 | $3,696 |
| Prolensa Bromfenac Sodium | 94 | 149 | 37 | $66K |
| Azathioprine Generic | 92 | 181 | 27 | $3,947 |
Brand drugs: - claims; generic drugs: 2,900 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen D Anesi $142K ($142K in general payments such as food, travel and fees) from 20 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $108K.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 88 | $108K |
| ANI Pharmaceuticals, Inc. ANIP | 35 | $24K |
| Abbvie Inc. ABBV | 29 | $6,515 |
| Bausch & Lomb Americas Inc. BLCO | 8 | $743 |
| Sight Sciences, Inc. SGHT | 11 | $642 |
| Alcon Vision LLC ALC | 11 | $629 |
| Tarsus Pharmaceuticals, Inc. TARS | 6 | $427 |
| Samsara Vision | 2 | $334 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 7 | $179 |
| Amgen Inc. AMGN | 8 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.